pSvida to list on Nasdaq

By Dylan Bushell-Embling
Tuesday, 10 June, 2008

WA-based biotech pSvida (ASX: PSD) is to reincorporate onto the Nasdaq, the American stock exchange.

The re-incorporation plan was first mooted in April. At a shareholders' meeting today, 94 per cent of shareholders, 192 in total, voted for the resolution, while six voted against it.

Between them the 192 shareholders hold around 96 per cent of the voting power.

The shareholders also voted to adopt a new employee incentive plan.

Related News

Hormone therapy shifts body proteins to match gender identity

Researchers have discovered that gender-affirming hormone therapy can alter body proteins to...

Targeting 'molecular bodyguards' weakens prostate cancer cells

Research reveals that two enzymes — PDIA1 and PDIA5 — act as 'molecular...

Females found to carry a higher genetic risk of depression

An international team of scientists has discovered about twice as many genetic 'flags'...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd